PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A sharp increase in the price of the gout drug colchicine led to lower use and poorer disease control, UCLA research suggests

The price jump was a result of an unusual FDA policy that eliminated lower-priced alternatives; government policies and manufacturer decisions could similarly affect the price and use of other drugs

2023-05-08
(Press-News.org) FINDINGS

Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011. Out-of-pocket costs for patients who took the drug jumped more than four-fold from $7.37 to $39.49 over the same period. Use of colchicine dropped 17% during this time and 27% over the following decade. Patients turned to alternative medications for gout such as allopurinol and corticosteroids. However, disease control appeared to worsen, as emergency department use by patients with gout increased by 39.8% and rheumatology doctor visits increased by 10.5% over the following decade.

 

BACKGROUND

Prior to 2010 the FDA had not formally approved colchicine for any particular clinical condition. That year, however, under its Unapproved Drug Initiative, the FDA approved Colcrys after its manufacturer conducted a clinical trial, and it removed other, much lower-priced, versions of colchicine from the market.

 

METHOD

The researchers analyzed 2007-2019 data for more than 2.7 million patient-years from MarketScan (IBM), which comprises a large sample of people with either employer-sponsored health insurance or employer-sponsored Medicare supplemental plans.

 

The researchers note some limitations to the study. They include a lack of a control group, the patient mix could have changed over time, gout severity and functional impairment among patients were not known, possible use of over-the-counter medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) could not be determined, and the findings may not be applicable to people without employer-sponsored health coverage.

 

IMPACT

The findings of this case study may have implications for other drugs that undergo large price increases and can serve as a useful data point for policies that could affect the price of drugs.

 

COMMENT

 “A rather unique FDA policy resulted in the loss of competitors to colchicine from the market, which led to an enormous increase in its price,” said study lead Dr. Dan Ly, assistant professor of medicine in the division of general internal medicine and health service research at the David Geffen School of Medicine at UCLA. “As a result, use of colchicine dropped. While patients with gout turned to other medications to treat their gout, such medications didn’t do exactly what colchicine did and had different side effects, possibly limiting their use. And therefore it appears, based on the increase in number of emergency department and specialist visits for patients with gout, that their disease control got worse. This case of colchicine speaks to the possible clinical consequences of other policies and manufacturer decisions that result in significant jumps in the prices of other drugs.”

 

 

AUTHORS

Additional authors are Mia Giuriato and Dr. Zirui Song of Harvard University

 

JOURNAL

The study will be published in the peer-reviewed JAMA Internal Medicine

 

FUNDING

The study was funded by the Director’s Early Independence Award, the National Institutes of Health, and Arnold Ventures.

 

DISCLOSURE

Song received fees from the Research Triangle Institute for work on Medicare risk adjustment for consultation on legal cases that were not associated with this work.

END


ELSE PRESS RELEASES FROM THIS DATE:

An unprecedented view of gene regulation

2023-05-08
CAMBRIDGE, MA -- Much of the human genome is made of regulatory regions that control which genes are expressed at a given time within a cell. Those regulatory elements can be located near a target gene or up to 2 million base pairs away from the target. To enable those interactions, the genome loops itself in a 3D structure that brings distant regions close together. Using a new technique, MIT researchers have shown that they can map these interactions with 100 times higher resolution than has previously been possible. “Using this method, we generate the highest-resolution maps of the 3D genome that have ever been generated, and what we see are a lot of interactions between ...

AI helps create better, simpler hepatitis, COVID-19 tests

2023-05-08
Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fueled improvements. University of Florida scientists have used artificial intelligence tools to simplify a test that works for both hepatitis C and SARS-CoV-2, the virus that causes COVID-19. The simplified test happens in one small test tube in just a few minutes. With further refinement, it could come to doctor’s offices soon and, one day, even home tests that are as easy as a pregnancy test. “We are trying to build a home-based test that is as reliable as a lab-based test,” said Piyush ...

Leaky-wave metasurfaces: A perfect interface between free-space and integrated optical systems

Leaky-wave metasurfaces: A perfect interface between free-space and integrated optical systems
2023-05-08
New York, NY—May 8, 2023—Researchers at Columbia Engineering have developed a new class of integrated photonic devices--“leaky-wave metasurfaces”--that can convert light initially confined in an optical waveguide to an arbitrary optical pattern in free space. These devices are the first to demonstrate simultaneous control of all four optical degrees of freedom, namely, amplitude, phase, polarization ellipticity, and polarization orientation--a world record. Because the devices are so thin, transparent, and compatible with photonic integrated circuits ...

AI predicts future pancreatic cancer

2023-05-08
An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records, according to new research led by investigators at Harvard Medical School and the University of Copenhagen, in collaboration with VA Boston Healthcare System, Dana-Farber Cancer Institute, and the Harvard T.H. Chan School of Public Health. The findings, published May 8 in Nature Medicine, suggest that AI-based population screening could be valuable in finding those at elevated risk for the disease and could expedite the diagnosis of a condition ...

Tiny microbes could brew big benefits for green biomanufacturing

Tiny microbes could brew big benefits for green biomanufacturing
2023-05-08
A research team led by Lawrence Berkeley National Laboratory (Berkeley Lab) and UC Berkeley has engineered bacteria to produce new-to-nature carbon products that could provide a powerful route to sustainable biochemicals. The advance – which was recently announced in the journal Nature – uses bacteria to combine natural enzymatic reactions with a new-to-nature reaction called the “carbene transfer reaction.” This work could also one day help reduce industrial emissions because it offers sustainable ...

Human Brain Project: Study presents large brain-like neural networks for AI

2023-05-08
In a new study in Nature Machine Intelligence*, researchers Bojian Yin and Sander Bohté from the HBP partner Dutch National Research Institute for Mathematics and Computer Science (CWI) demonstrate a significant step towards artificial intelligence that can be used in local devices like smartphones and in VR-like applications, while protecting privacy. They show how brain-like neurons combined with novel learning methods enable training fast and energy-efficient spiking neural networks on a large scale. Potential applications range from wearable AI to speech recognition and Augmented Reality.  While modern artificial neural ...

Detailed image of the human retina

Detailed image of the human retina
2023-05-08
What cell types are found in which human tissue, and where? Which genes are active in the individual cells, and which proteins are found there? Answers to these questions and more are to be provided by a specialised atlas – in particular how the different tissues form during embryonic development and what causes diseases. In creating this atlas, researchers aim to map not only tissue directly isolated from humans, but also structures called organoids. These are three-dimensional clumps of tissue that are cultivated in the laboratory and develop in a way similar ...

Welcoming Dr Ece Uzun, MS, PhD as the Editor-in-Chief for JMIR Bioinformatics and Biotechnology

Welcoming Dr Ece Uzun, MS, PhD as the Editor-in-Chief for JMIR Bioinformatics and Biotechnology
2023-05-08
JMIR Bioinformatics and Biotechnology and JMIR Publications are thrilled to announce and welcome Dr Ece Uzun as Editor-in-Chief for JMIR Bioinformatics and Biotechnology.  Dr. Uzun is currently the Director of Clinical Bioinformatics and Associate Director of Clinical Cancer Informatics and Data Science (CCIDS) at Lifespan and an Assistant Professor of Pathology and Laboratory Medicine at Brown University Alpert Medical School.  She has a B.S in Chemical Engineering and M.Sc in Biological Sciences and Bioengineering. She completed her PhD in Chemical Engineering at Northeastern University in 2010 and focused ...

Elucidating the mysteries of enzyme evolution at the macromolecular level

Elucidating the mysteries of enzyme evolution at the macromolecular level
2023-05-08
Professor Nicolas Doucet and his team at Institut national de la recherche scientifique (INRS) made a major breakthrough earlier this year in the field of evolutionary conservation of molecular dynamics in enzymes. Their work, published in the journal Structure, points to potential applications in health, including the development of new drugs to treat serious diseases such as cancer or to counter antibiotic resistance.  As a researcher specializing in protein dynamics, Professor Doucet is captivated by things that are invisible to the naked eye, yet full of mysteries and essential to all forms of life. He studies proteins ...

Recent research advances on historical artifacts and their preservation

2023-05-08
Because we don’t have crystal balls to show us how the world used to look, scientists must rely on preserved artifacts and specimens to provide the details. Below are some recent papers published in ACS journals that have unearthed insights from historic items and provided suggestions for protecting relics. Reporters can request free access to these papers by emailing newsroom@acs.org. “Two Pathways for the Degradation of Orpiment Pigment (As2S3) Found in Paintings” Journal of the American Chemical Society April 14, 2023 Oil paintings created before the 19th century often ...

LAST 30 PRESS RELEASES:

New research reveals significant prevalence of valvular heart disease among older Americans

Outdoor air pollution linked to higher incidence of breast cancer

Thiophene-doped fully conjugated covalent organic frameworks for efficient photocatalytic hydrogen peroxide production

Earth’s ‘boring billion years’ created the conditions for complex life

Health data for 57 million people in England show changing patterns of heart diseases before, during and after the pandemic

Cycling ‘near misses’ in London worst at rush hour and on roads without dedicated infrastructure

Roots in the dark: Russian scientists uncover hidden carbon dioxide uptake in plant roots

Biochar and hydrochar show contrasting climate effects in boreal grasslands

Turning trash into treasure: Scientists transform waste plastics into high-value carbon materials

Boys don’t cry? How picture books can teach gendered ideas about pain

In global collaboration, IU scientists unlock secrets to the building blocks of the universe

Young adults fear mass shootings but don’t necessarily support gun control

How unlocking ‘sticky’ chemistry may lead to better, cleaner fuels

Cutting balloon treatment prior to stent placement comparable to intravascular lithotripsy for patients with calcified coronary artery disease

Novel sirolimus-eluting balloon appears noninferior to conventional therapies for treatment of in-stent restenosis

Nearly half of US workers don’t know work experience could count toward a degree, according to University of Phoenix survey

Super-high-pressure non-compliant balloons for treatment of calcified coronary lesions noninferior to intravascular lithotripsy

Saudi Native Dr. Hani K. Najm named next vice president of the American College of Cardiology

Getting steps in one long walk a day cuts risk of death and CVD better than multiple short walks

The way you walk: 10–15 minute bouts of walking better for your cardiovascular health than shorter strolls

Beyond electronics: harnessing light for faster computing

Researchers find possible cause for increasing polarization

From soft to solid: How a coral stiffens its skeleton on demand

New software tool MARTi fast-tracks identification and response to microbial threats

Rare brain cell may hold the key to preventing schizophrenia symptoms

A new tool to find hidden ‘zombie cells’

New Cleveland Clinic research finds up to 5% of Americans carry genetic mutations associated with cancer risk

Once tadpoles lose lungs, they never get them back

Small group of users drive invasive species awareness on social media

One bad safety review can tank an Airbnb booking — Even among thousands of positive ones, new study finds

[Press-News.org] A sharp increase in the price of the gout drug colchicine led to lower use and poorer disease control, UCLA research suggests
The price jump was a result of an unusual FDA policy that eliminated lower-priced alternatives; government policies and manufacturer decisions could similarly affect the price and use of other drugs